Alex Graudenzi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alex Graudenzi

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

British Journal of Haematology|April 25, 2022

Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.

Cancer Research|June 11, 2025

Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.

Nature Communications|February 3, 2025

Early tolerance and late persistence as alternative drug responses in cancerSimona Punzi, Davide Cittaro, Guido Gatti, et al.

NEJM Evidence|May 26, 2026

Prognostic Score for Myelodysplastic Syndromes Based on Molecular EvolutionIvan Civettini, Federica Malighetti, Matteo Villa, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

British Journal of Haematology|April 25, 2022

Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.

Cancer Research|June 11, 2025

Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype ParadigmErica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos, et al.

Nature Communications|February 3, 2025

Early tolerance and late persistence as alternative drug responses in cancerSimona Punzi, Davide Cittaro, Guido Gatti, et al.

NEJM Evidence|May 26, 2026

Prognostic Score for Myelodysplastic Syndromes Based on Molecular EvolutionIvan Civettini, Federica Malighetti, Matteo Villa, et al.

Pageof 5